Figure 3.

Forest plot of subgroup analyses of progression‐free survival based on computer algorithm, intent‐to‐treat population (Study MMY3003).

Abbreviations: CA, Canada; CI, confidence interval; CrCl, creatine clearance rate; DRd, daratumumab + lenalidomide + low‐dose dexamethasone; ECOG, Eastern Cooperative Oncology Group; EU, European Union; EVT/N, number of progression events or deaths/total number; ISS, International Staging System; MM, multiple myeloma; NE, not estimated; PI, proteasome inhibitor; Rd, lenalidomide + low‐dose dexamethasone.